Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 177

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease

Seminerio, Jennifer L., Koutroubakis, Ioannis E., Ramos-Rivers, Claudia, Hashash, Jana G., Dudekula, Anwar, Regueiro, Miguel, Baidoo, Leonard, Barrie, Arthur, Swoger, Jason, Schwartz, Marc, Weyant, Katherine, Dunn, Michael A., Binion, David G. · 2015 · Inflammatory Bowel Diseases

Abstract

BACKGROUND: Obesity has been linked with a proinflammatory state and the development of inflammatory diseases. Data on the clinical course and treatment of obese patients with inflammatory bowel disease (IBD) are limited. We used an institutional IBD registry to investigate the impact of obesity on IBD severity and treatment. METHODS: This was a retrospective analysis of prospectively collected data for 3 years (2009-2011). Patients with IBD were categorized by body mass index (BMI). IBD-related quality of life, biochemical markers of inflammation, comorbidities, health care utilization, and treatment were characterized. Obesity was defined as a BMI ≥30 (type I: 30-34.9, type II: 35-39.9, and type III ≥40). RESULTS: Among 1494 patients with IBD, 71.9% were above their ideal BMI and 31.5% were obese. Obesity was more common in ulcerative colitis compared with patients with Crohn's disease (P = 0.04). Obese class II and class III patients were predominantly female. Obesity in IBD was associated with female gender (P < 0.0001), diabetes mellitus (P < 0.001), hypertension (P < 0.001), hyperlipidemia (P < 0.001), poor quality of life (P < 0.0001), and increased rates of C-reactive protein elevation (P = 0.008). In logistic regression analysis, quality of life and C-reactive protein elevation were not independently correlated with obesity. There was no association between increasing BMI and annual prednisone use, emergency department visits, hospitalization, and surgery. Obesity was associated with lower milligrams per kilogram doses of purine analogs and biologics. CONCLUSIONS: Obesity in IBD is not associated with increased health care utilization and IBD-related surgeries. Optimal regimens for drug dosing in obese patients with IBD have yet to be defined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mib.0000000000000560

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 177

Metadata

Authors
Seminerio, J. L., Koutroubakis, I. E., Ramos-Rivers, C., Hashash, J. G., Dudekula, A., Regueiro, M., Baidoo, L., Barrie, A., Swoger, J., Schwartz, M., Weyant, K., Dunn, M. A., & Binion, D. G.
Venue
Inflammatory Bowel Diseases
Published
2015-12
Volume
21
Issue
12
Pages
2857-2863
ISSN
1078-0998 (ISSN-L)
OpenAlex
W1054573222
Cited by
177
References
2
FWCI
8.43
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease. https://app.cochat.ai/papers/10.1097/mib.0000000000000560
The paper
Seminerio, J. L., Koutroubakis, I. E., Ramos-Rivers, C., Hashash, J. G., Dudekula, A., Regueiro, M., Baidoo, L., Barrie, A., Swoger, J., Schwartz, M., Weyant, K., Dunn, M. A., & Binion, D. G. (2015). Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. https://doi.org/10.1097/mib.0000000000000560

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.